Correlation Between Medicenna Therapeutics and Arch Biopartners
Can any of the company-specific risk be diversified away by investing in both Medicenna Therapeutics and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicenna Therapeutics and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicenna Therapeutics Corp and Arch Biopartners, you can compare the effects of market volatilities on Medicenna Therapeutics and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicenna Therapeutics with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicenna Therapeutics and Arch Biopartners.
Diversification Opportunities for Medicenna Therapeutics and Arch Biopartners
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Medicenna and Arch is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Medicenna Therapeutics Corp and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and Medicenna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicenna Therapeutics Corp are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of Medicenna Therapeutics i.e., Medicenna Therapeutics and Arch Biopartners go up and down completely randomly.
Pair Corralation between Medicenna Therapeutics and Arch Biopartners
Assuming the 90 days trading horizon Medicenna Therapeutics Corp is expected to generate 2.3 times more return on investment than Arch Biopartners. However, Medicenna Therapeutics is 2.3 times more volatile than Arch Biopartners. It trades about 0.06 of its potential returns per unit of risk. Arch Biopartners is currently generating about 0.02 per unit of risk. If you would invest 77.00 in Medicenna Therapeutics Corp on August 31, 2024 and sell it today you would earn a total of 95.00 from holding Medicenna Therapeutics Corp or generate 123.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Medicenna Therapeutics Corp vs. Arch Biopartners
Performance |
| Timeline |
| Medicenna Therapeutics |
| Arch Biopartners |
Medicenna Therapeutics and Arch Biopartners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medicenna Therapeutics and Arch Biopartners
The main advantage of trading using opposite Medicenna Therapeutics and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicenna Therapeutics position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.| Medicenna Therapeutics vs. Aptose Biosciences | Medicenna Therapeutics vs. Oncolytics Biotech | Medicenna Therapeutics vs. Helix BioPharma Corp |
| Arch Biopartners vs. NervGen Pharma Corp | Arch Biopartners vs. Nanalysis Scientific Corp | Arch Biopartners vs. Perimeter Medical Imaging | Arch Biopartners vs. Medicenna Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |